News

 {Photo credit: Kenza Abu-Arja/MSH}From left to right: Chris Collins; Loyce Pace; Willo Brock.Photo credit: Kenza Abu-Arja/MSH

On July 16, Management Sciences for Health (MSH), in conjunction with the office of Congressman Ami Bera (D-CA), hosted “The rising threat of antimicrobial resistance: What happens when diseases resist the drugs that we’ve designed to fight them?” to discuss antimicrobial resistance (AMR), its consequences, and the efforts needed to fight it. This event, the second in a series on global health security funded by the James M. and Cathleen D.

Nancy Ngum and Paul Tanui (AUDA-NEPAD), Ms. Mimi Darko (Ghana FDA), and Kate Kikule (MTaPS)

Regional regulatory leaders, representatives from academia, and development organizations gathered in Accra, Ghana, in June to review a new monitoring and evaluation (M&E) tool that promises to improve access to safe, affordable medicines in several African countries by measuring the performance of Regional Centres of Regulatory Excellence (RCOREs).The African Union Development Agency (AUDA-NEPAD), in collaboration with the USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) program, supported the validation of the M&E tool.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

MSH’s President and CEO, Marian W. Wentworth, will join the World Health Organization (WHO)’s Malaria Vaccine Advisory Committee (MALVAC) for a two-year appointment.

Pages